Floatz logo

Sitagliptin

Surgery

Zealand University HospitalSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
81/ 100

Competitive context

46 Active assets in the Surgery cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
Claus Anders Bertelsen, PhD, MD
Phase 4BB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
University of California, Davis
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Ain Shams University
Phase 4BB
Ferric Carboxymaltose [Ferinject]
Jon Unosson
Phase 4BB
FENTANYL
University of Sao Paulo General Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Sitagliptin is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →
prediabetes syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →